CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing ...

DNA commodification is no longer a future concern; it’s a present reality. Beyond charging users for their services, some ...

The company is scheduled to hold its third quarter 2024 earnings conference call after the market closes on Thursday November 7, 2024, and intends to provide additional information regarding its ...

Facebook’s business model revolves around sharing information with many third parties. Unlike medical providers, genetic testing companies aren’t bound by health privacy laws such as HIPAA despite the ...

GeneDx Holdings (NASDAQ:WGS) stock is trading higher on Tuesday. The genetic testing company reported a third-quarter EPS loss of $(0.31), compared to $(1.64) reported a year ago, beating the ...

Adam Brufsky, MD, PhD, professor of medicine at the University of Pittsburgh School of Medicine; Megan Kruse, MD, breast medical oncologist at Cleveland Clinic; and Ruta Rao, MD, professor of medicine ...

The growing interest among pet owners in understanding their pets’ genetic backgrounds is driving demand for pet DNA testing ...